Evidence map›Paper›PMID 29595877›Full record

ArticlePhysiological reports2018

Effects of HIV-1 gp120 and tat on endothelial cell sensescence and senescence-associated microRNAs.

Jamie G Hijmans, Kelly Stockleman, Whitney Reiakvam, Ma'ayan V Levy, Lillian M Brewster, Tyler D Bammert, Jared J Greiner, Elizabeth Connick, Christopher A DeSouza

Open access · goldAbstract read
In one paragraph

Article in Physiological reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Cardiovascular Disease and Thrombosis in HIV Infection.Arteriosclerosis, thrombosis, and vascular biology · 2023
    Review
  10. MicroRNA-34a: the bad guy in age-related vascular diseases.Cellular and molecular life sciences : CMLS · 2021
    Review
  11. Review
  12. Review
  13. Cerebral Vascular Toxicity of Antiretroviral Therapy.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2021
    Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Effects of HIV-1 gp120 and TAT-derived microvesicles on endothelial cell function.Journal of applied physiology (Bethesda, Md. : 1985) · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Jamie G HijmansDepartment of Integrative Physiology, Integrative Vascular Biology Laboratory, University of Colorado, Boulder, Colorado.
Kelly StocklemanDepartment of Integrative Physiology, Integrative Vascular Biology Laboratory, University of Colorado, Boulder, Colorado.
Whitney ReiakvamDepartment of Integrative Physiology, Integrative Vascular Biology Laboratory, University of Colorado, Boulder, Colorado.
Ma'ayan V LevyDepartment of Integrative Physiology, Integrative Vascular Biology Laboratory, University of Colorado, Boulder, Colorado.
Lillian M BrewsterDepartment of Integrative Physiology, Integrative Vascular Biology Laboratory, University of Colorado, Boulder, Colorado.
Tyler D BammertDepartment of Integrative Physiology, Integrative Vascular Biology Laboratory, University of Colorado, Boulder, Colorado.
Jared J GreinerDepartment of Integrative Physiology, Integrative Vascular Biology Laboratory, University of Colorado, Boulder, Colorado.
Elizabeth ConnickDepartment of Medicine, Division of Infectious Disease, University of Arizona, Tucson, Arizona.
Christopher A DeSouzaDepartment of Integrative Physiology, Integrative Vascular Biology Laboratory, University of Colorado, Boulder, Colorado.
Integra (United States) · USUniversity of Colorado Boulder · USUniversity of Arizona · US

Funding

HIV-1, Insufficient Sleep and Vascular Endothelial DysfunctionR01HL131458 · NHLBI · UNIVERSITY OF COLORADO · PI CONNICK, ELIZABETH, DESOUZA, CHRISTOPHER A · 2016 to 2019
$3.0M
NHLBI NIH HHS R01 HL131458
6 · The paper itself

Abstract

The aim of this study was to determine, in vitro, the effects of X4 and R5 HIV-1 gp120 and Tat on: (1) endothelial cell senescence and (2) endothelial cell microRNA (miR) expression. Endothelial cells were treated with media without and with: R5 gp120 (100 ng/mL), X4 gp120 (100 ng/mL), or Tat (500 ng/mL) for 24 h and stained for senescence-associated β-galactosidase (SA-β-gal). Cell expression of miR-34a, miR-217, and miR-146a was determined by RT-PCR. X4 and R5 gp120 and Tat significantly increased (~100%) cellular senescence versus control. X4 gp120 significantly increased cell expression of miR-34a (1.60 ± 0.04 fold) and miR-217 (1.52 ± 0.18), but not miR-146a (1.25 ± 0.32). R5 gp120 significantly increased miR-34a (1.23 ± 0.07) and decreased miR-146a (0.56 ± 0.07). Tat significantly increased miR-34a (1.49 ± 0.16) and decreased miR-146a (0.55 ± 0.23). R5 and Tat had no effect on miR-217 (1.05 ± 0.13 and 1.06 ± 0.24; respectively). HIV-1 gp120 (X4 and R5) and Tat promote endothelial cell senescence and dysregulation of senescence-associated miRs.

Indexed as

HIV Envelope Protein gp120tat Gene Products, Human Immunodeficiency VirusCardiovascular DiseasesCells, CulturedCellular SenescenceEndothelial CellsHIV InfectionsHumansMicroRNAsgp120 protein, Human immunodeficiency virus 1HIV Envelope Protein gp120MicroRNAstat Gene Products, Human Immunodeficiency VirusEndothelial cellsmicroRNAsenescenceviral proteins

Identifiers

PMID29595877
PMCPMC5875545
OpenAlexW2796369912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.